OVENTUS LAUNCHES $12M ASX TILT

Written on the 17 June 2016

OVENTUS LAUNCHES $12M ASX TILT

A BRISBANE-based sleep disorder device manufacturer and developer has launched an IPO to raise $12 million.

Oventus is offering 24 million shares to be listed on the ASX at 50 cents apiece, led and underwritten by Bell Potter Securities.

The company's O2VENT treats sleep apnoea and snoring by creating an airway to bypass nasal, soft palate and tongue obstructions.

The US Food and Drug Administration has approved the appliance for marketing, paving the way for international expansion.

Funds raised under the offer will be used to continue the commercialisation and distribution of the O2VENT in Australia, develop additional devices and expand to new markets.

Oventus chairman Mel Bridges says the company plans to become a global leader in the treatment of obstructive sleep apnoea.

The condition involves repeated episodes of airway obstruction during sleep and also has a direct link to more serious health issues.

"We are pleased to invite investors to join with Oventus as we embark on an exciting development program and help address a significant health and lifestyle issue for millions of people around the world," Bridges says.

Oventus estimates that the current global sleep apnoea market for therapeutic devices is worth US$3.5 billion and growing by 7.4 per cent each year.

The company lodged its prospectus with the ASX on June 8.

 


Latest News

AUSTRALIA READY TO DISRUPT GLOBAL CARBON FIBRE MANUFACTURING

AUSTRALIA for the first time has the capacity to produce carbon fibre from scratch and at scale, following the launch...

HONG KONG FUND INVESTS $212.8 MILLION IN G8 EDUCATION

G8 EDUCATION (ASX: GEM) has secured $212.8 million from Hong Kong-based CFCG Investment Partners to pay down debt and...

MERGER DELIVERS THE FINANCIAL GOODS FOR TERRY WHITE

TERRY White Group has posted a solid half-year net profit of $1.3 million amid a period of major transformation fo...

BLUE SKY APPOINTS TWO NEW INDEPENDENT DIRECTORS

BLUE Sky Alternative Investments (ASX: BLA) has appointed two new independent, non-executive directors to its board: ...

Related News

WHY EMPLOYEE-OWNED COMPANIES ARE BEATING ASX200 SHARE PRICES

EMPLOYEE-owned companies command a higher share price than their publicly listed peers, reaping a 17 per cent prem...

RISE OF THE MACHINES HAS WORKERS SWEATING

UP TO 3.8 million Australian workers are fearful their job may soon be terminated by a robot, a new survey has shown....

LESS TALK, MORE SMALL BUSINESS ACTION IN 2017

THE future growth and prosperity of Australian SMEs could be undermined if governments lose sight of the sector...

TEST DRIVE A POST GRAD AT BOND

THERE'S only one way to really move your career into the fast lane, says Bond University, and 'test driving...

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter